Global Anti-malarial Medicines Market 2018-2022

抗マラリア薬の世界市場:アルテミシニン化合物、キノリン・関連化合物、その他化合物

◆タイトル:Global Anti-malarial Medicines Market 2018-2022
◆商品コード:IRTNTR23769
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年9月21日
◆ページ数:117
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、抗マラリア薬の世界市場について調査・分析し、市場概要、市場環境、抗マラリア薬市場規模、製品別(アルテミシニン化合物、キノリン・関連化合物、その他化合物) 分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。主な分析対象企業は、F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, Sun Pharmaceutical Industriesなどです。
・エグゼクティブサマリー
・調査範囲・調査手法
・抗マラリア薬の世界市場概要
・抗マラリア薬の世界市場環境
・抗マラリア薬の世界市場動向
・抗マラリア薬の世界市場規模
・抗マラリア薬の世界市場:業界構造分析
・抗マラリア薬の世界市場:製品別(アルテミシニン化合物、キノリン・関連化合物、その他化合物)
・抗マラリア薬の世界市場:地域別市場規模・分析
・抗マラリア薬の北米市場規模・予測
・抗マラリア薬のヨーロッパ・中東・アフリカ市場規模・予測
・抗マラリア薬のアジア太平洋市場規模・予測
・抗マラリア薬の主要国分析
・抗マラリア薬の世界市場:意思決定フレームワーク
・抗マラリア薬の世界市場:成長要因、課題
・抗マラリア薬の世界市場:競争環境
・抗マラリア薬の世界市場:関連企業情報(ベンダー分析)

About Malaria
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Technavio’s analysts forecast the Global Anti-malarial Medicines Market to grow at a CAGR of 4.76% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the anti-malarial medicines market. To calculate the market size, the report considers the revenue generated by sales of anti-malarial drugs across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, anti-malarial medicines market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Sun Pharmaceutical Industries
Market driver
• Strong funding to eradicate malaria
• For a full, detailed list, view our report

Market challenge
• Drug resistant pathogens
• For a full, detailed list, view our report

Market trend
• Enhancement of POC diagnostics and biomarkers for malaria
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE
PART 08: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Artemisinin compounds – Market size and forecast 2017-2022
• Quinolines and related compounds – Market size and forecast 2017-2022
• Other compounds – Market size and forecast 2017-2022
• Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Sun Pharmaceutical Industries
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global infectious disease medicines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global anti-malarial medicines market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global anti-malarial medicines market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Pipeline landscape by development phase 2017-2018
Exhibit 19: Pipeline molecules for the treatment of malaria 2017-2018
Exhibit 20: Global anti-malarial medicines market by product – Market share 2017-2022 (%)
Exhibit 21: Comparison by product
Exhibit 22: Artemisinin compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global anti-malarial medicines market by artemisinin compounds – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global anti-malarial medicines market by quinolines and related compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global anti-malarial medicines market by quinolines and related compounds – Year-over-year growth 2018-2022 (%)
Exhibit 26: Global anti-malarial medicines market by other compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Global anti-malarial medicines market by other compounds – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global anti-malarial medicines market by geography – Market share 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Percentage of people at risk of malaria worldwide
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: F. Hoffmann-La Roche: Overview
Exhibit 49: F. Hoffmann-La Roche – Business segments
Exhibit 50: F. Hoffmann-La Roche – Organizational developments
Exhibit 51: F. Hoffmann-La Roche – Geographic focus
Exhibit 52: F. Hoffmann-La Roche – Segment focus
Exhibit 53: F. Hoffmann-La Roche – Key offerings
Exhibit 54: F. Hoffmann-La Roche – Key customers
Exhibit 55: GlaxoSmithKline: Overview
Exhibit 56: GlaxoSmithKline – Business segments
Exhibit 57: GlaxoSmithKline – Organizational developments
Exhibit 58: GlaxoSmithKline – Geographic focus
Exhibit 59: GlaxoSmithKline – Segment focus
Exhibit 60: GlaxoSmithKline – Key offerings
Exhibit 61: GlaxoSmithKline – Key customers
Exhibit 62: Novartis: Overview
Exhibit 63: Novartis – Business segments
Exhibit 64: Novartis – Organizational developments
Exhibit 65: Novartis – Geographic focus
Exhibit 66: Novartis – Segment focus
Exhibit 67: Novartis – Key offerings
Exhibit 68: Novartis – Key customers
Exhibit 69: Pfizer: Overview
Exhibit 70: Pfizer – Business segments
Exhibit 71: Pfizer – Organizational developments
Exhibit 72: Pfizer – Geographic focus
Exhibit 73: Pfizer – Segment focus
Exhibit 74: Pfizer – Key offerings
Exhibit 75: Pfizer – Key customers
Exhibit 76: Sun Pharmaceutical Industries: Overview
Exhibit 77: Sun Pharmaceutical Industries – Business segments
Exhibit 78: Sun Pharmaceutical Industries – Organizational developments
Exhibit 79: Sun Pharmaceutical Industries – Geographic focus
Exhibit 80: Sun Pharmaceutical Industries – Segment focus
Exhibit 81: Sun Pharmaceutical Industries – Key offerings
Exhibit 82: Sun Pharmaceutical Industries – Key customers



【掲載企業】

F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, Sun Pharmaceutical Industries

★調査レポート[抗マラリア薬の世界市場:アルテミシニン化合物、キノリン・関連化合物、その他化合物] (Global Anti-malarial Medicines Market 2018-2022 / IRTNTR23769)販売に関する免責事項
[抗マラリア薬の世界市場:アルテミシニン化合物、キノリン・関連化合物、その他化合物] (Global Anti-malarial Medicines Market 2018-2022 / IRTNTR23769)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆